Title : Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.

Pub. Date : 2015 Nov 10

PMID : 26517678






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition, the SFKs inhibitor dasatinib inhibited the proliferation of BTZ-resistant cells, preventing the binding of CD19 with Lyn and PI3K p85. Dasatinib CD19 antigen Mus musculus